Chondroitin-ACOS, 5% ointment 30 g

Chondroitin-ACOS has chondroprotective, stimulating the regeneration of cartilage tissue, anti-inflammatory, analgesic effect.

Pharmacodynamics

Chondroitin-ACOS contains chondroitin sulfate – a stimulator of cartilage regeneration in the joints (chondroprotector) derived from the cartilage of the bovine trachea and dimethyl sulfoxide.

Chondroitin sulfate is a high molecular weight mucopolysaccharide that inhibits the process of destruction of cartilage tissue and accelerates its repair. Inhibits enzymes that cause cartilage tissue damage and prevents its degradation; stimulates biosynthesis of glycosaminoglycans by chondrocytes; promotes restoration of articular bag and cartilage surfaces of joints, increases production of intraarticular fluid.

It improves phosphorus-calcium metabolism and reduces calcium loss in cartilage tissue, slows bone tissue resorption, normalizes metabolism in hyaline tissue, accelerates regeneration (restoration) and inhibits cartilage degeneration (destruction) processes. Structurally similar to heparin, it prevents the formation of fibrin clots in the synovial and subchondral microcirculatory system. As a result, it reduces pain and increases the mobility of the affected joints.

Dimethylsulfoxide which is included in the ointment has anti-inflammatory, analgesic and fibrinolytic effects, promotes better penetration of chondroitin sulfate through cell membranes deep into tissues.

The Chondroitin-ACOS ointment has analgesic and anti-inflammatory activity, normalizes metabolism and stimulates the restoration processes in joint tissues, results in reduction or disappearance of pain in the joints, improves joint mobility and slows down the progression of osteoarthritis and osteochondrosis.

Indications

Treatment and prevention of osteochondrosis, osteoarthrosis of peripheral joints and spine.

Pharmacological effect

Chondroitin-AKOS has a chondroprotective, stimulating regeneration of cartilage tissue, anti-inflammatory, analgesic effect.

Pharmacodynamics

Chondroitin-AKOS contains chondroitin sulfate, a stimulator for the restoration of cartilage tissue in joints (chondroprotector), obtained from bovine tracheal cartilage, and dimethyl sulfoxide.

Chondroitin sulfate is a high-molecular mucopolysaccharide that inhibits the processes of destruction of cartilage tissue and accelerates the processes of its restoration. Suppresses enzymes that cause damage to cartilage tissue and prevents its degradation; stimulates the biosynthesis of glycosaminoglycans by chondrocytes; promotes the restoration of the joint capsule and cartilaginous surfaces of the joints, increases the production of intra-articular fluid.

Improves phosphorus-calcium metabolism and reduces calcium loss in cartilage tissue, slows down bone resorption, normalizes metabolism in hyaline tissue, accelerates regeneration (recovery) processes and inhibits degeneration (destruction) of cartilage tissue. Structurally close to heparin, it prevents the formation of fibrin blood clots in the synovial and subchondral microvasculature. As a result of the effect, pain decreases and mobility of the affected joints increases.

Dimethyl sulfoxide, which is part of the ointment, has an anti-inflammatory, analgesic and fibrinolytic effect, promotes better penetration of chondroitin sulfate through cell membranes deep into tissues.

Chondroitin-AKOS ointment has an analgesic and anti-inflammatory effect, normalizes metabolism and stimulates restoration processes in joint tissues, leads to a reduction or disappearance of pain in the joints, improves joint mobility, and slows down the progression of osteoarthrosis and osteochondrosis.

Special instructions

Avoid getting the ointment on mucous membranes and open wounds.

Active ingredient

Chondroitin sulfate

Composition

100 g ointment contains:

active ingredients:

chondroitin sodium sulfate (in terms of dry matter) 5 g,

dimexide (dimethyl sulfoxide) 10 g,

excipients (base):

lanolin anhydrous;

medical Vaseline;

purified water

Pregnancy

Do not use Chondroitin-AKOS ointment without consulting a doctor during pregnancy and breastfeeding, as well as in childhood.

Contraindications

Hypersensitivity to the components of the drug Chondroitin-AKOS.
acute inflammatory processes in the wound area;
widespread tissue necrosis;
excessive granulation;
violation of the integrity of the skin at the sites of intended application.

With caution: do not use Chondroitin-AKOS ointment without consulting a doctor during pregnancy and breastfeeding, as well as in childhood.

Side Effects

in rare cases, allergic reactions are possible, requiring discontinuation of the drug.

Interaction

There have been no cases of negative drug interactions when prescribing the ointment during therapy with other drugs included in generally accepted treatment regimens for degenerative diseases of the joints and spine.

Storage conditions

In a place protected from light, at a temperature of 2–20 °C

Shelf life

3 years

Manufacturer

Sintez, Russia